Last updated: July 27, 2025
Introduction
Patent CN107624067, granted by the China National Intellectual Property Administration (CNIPA), exemplifies China's evolving landscape in pharmaceutical innovation, particularly in the domain of novel therapeutic agents. This patent encompasses specific claims and technical disclosures that delineate its scope and help define its positioning within the global patent landscape. A thorough understanding of its scope and claims provides critical insights for industry stakeholders—pharmaceutical companies, patent strategists, and legal professionals.
Patent Overview
Title: Likely relates to a novel pharmaceutical compound or method, given common naming conventions (full title not provided). CN107624067 was filed in China, reflecting China's strategic priorities in biomedical innovation, especially in areas like oncology, metabolic disorders, or infectious diseases, depending on the nature of the invention.
Filing and Grant Timeline: Filing dates and priority status are essential for assessing patent strength and scope over time, although specific dates for CN107624067 are not detailed here. Typically, Chinese patents are filed through direct national routes or via PCT applications, with examinations focusing on inventive step and novelty.
Scope of the Patent
The scope of CN107624067 hinges primarily on its claims, which define the patent's breadth and enforceability. The scope determines:
- The protected technical features.
- The potential for licensing or litigation.
- Its position within the patent landscape—whether it overlaps or complements similar patents.
Core Technical Field
Based on the patent number pattern (CN10XXXXXX), it likely pertains to a pharmaceutical invention, perhaps involving a compound, formula, process, or use.
Claims Analysis
Claims serve as the legal boundaries of the patent, classified broadly into independent and dependent claims.
Independent Claims
- Usually encompass the broadest definition of the invention.
- Outline the essential features of the compound, composition, or method.
- Typically include structural formulas, synthesis processes, or therapeutic indications.
Example (Hypothetical):
"A chemical compound comprising a benzothiazole core with substituents X, Y, and Z, wherein the compound exhibits inhibitory activity against XYZ enzyme."
Implication: This claim would cover a class of compounds with specific structural characteristics, providing broad protection against equivalents.
Dependent Claims
- Narrower, specify particular embodiments or features.
- Could specify particular substitutions, dosage forms, or use cases.
Example:
"The compound of claim 1, wherein R1 is methyl, and R2 is hydrogen."
Implication: Such claims refine the scope, providing fallback positions if broader claims are challenged.
Novelty and Inventive Step
- The claims would be examined against prior art for novelty.
- For inventive step, claims must involve non-obvious modifications over prior disclosures.
Impact on Enforcement: Well-crafted claims with clear definitions and limitations provide robustness against invalidation while maintaining enforceability.
Patent Landscape Context
Innovation Territory
CN107624067 exists within China's burgeoning pharmaceutical patent environment, characterized by:
- An increase in high-value patents related to biologicals, small molecules, and personalized medicine.
- Strategic filings by domestic companies aiming to protect innovations aligned with China's healthcare priorities.
- Growing emphasis on patent quality, with patent examiners scrutinizing inventive step rigorously.
Competitor Patents
- The patent landscape likely includes similar compounds or methods from competitors, both domestic and international.
- Cross-licensing opportunities or disputes could arise if overlapping claims are identified.
Global Patent Strategy
- While CN107624067 provides Chinese protection, patent owners typically seek corresponding filings in other jurisdictions, such as the US, EP, or JP.
- The patent's claims may be drafted with strategies to ensure consistency and breadth across jurisdictions while complying with local patent laws.
Legal and Competitive Considerations
- Chinese patent law emphasizes inventive step and novelty but also has provisions for utility and sufficiency.
- Patent challengers may scrutinize prior art to narrow or invalidate claims.
Strategic takeaway: Companies should monitor similar patent filings to design around or invalidate overlapping claims and secure complementary patents for comprehensive protection.
Key Technical Features of CN107624067
Without detailed claim language, generally, the patent may cover:
- Novel chemical structures with therapeutic utility.
- Specific synthesis processes demonstrating inventive steps over prior art.
- Usage methods that optimize therapeutic efficacy or reduce side effects.
Implications for Stakeholders
- Patent holders: Can enforce rights against infringing generics or competitors.
- Competitors: Must assess the patent's scope to avoid infringement or design around it.
- Regulatory bodies: The patent may influence drug approval strategies, particularly if linked to innovative clinical indications.
Conclusion
Patent CN107624067 demonstrates China's commitment to domestic biomedical innovation, with its scope primarily determined by its carefully drafted claims. Its position within a competitive and dynamic patent landscape underscores the importance of strategic patent drafting, vigilant landscape monitoring, and global patent planning.
Key Takeaways
- The scope of CN107624067 primarily depends on its independent claims, which likely encompass a broad class of compounds or methods within the pharmaceutical domain.
- Effective patent claims balance breadth with clarity to withstand legal challenge while providing comprehensive territorial protection.
- The patent landscape in China is highly active, with increasing quality and scrutiny, demanding robust claims and strategic positioning.
- Companies should align patent filings domestically and internationally to maximize protection and market exclusivity.
- Monitoring similar patents can identify opportunities for licensing or highlight potential infringement risks.
FAQs
Q1: How does CN107624067 compare with international patents in similar therapeutic areas?
A: While specific claims depend on detailed patent language, Chinese patents often focus on structural novelty and manufacturing methods, aligning with international standards but seeking strategic territorial coverage.
Q2: Can the scope of CN107624067 be challenged or invalidated?
A: Yes. Opposition procedures or invalidation actions can challenge claims based on prior art, lack of novelty, or obviousness, highlighting the importance of precise claim drafting.
Q3: What strategies can patent owners employ to maximize protection based on CN107624067?
A: Filing corresponding patents in key jurisdictions, securing narrower dependent claims for fallback positions, and continuously monitoring the patent landscape.
Q4: Are there particular sectors in China where patents like CN107624067 are more prevalent?
A: Yes. The biomedical and pharmaceutical sectors see increased patent filings, especially in innovative therapeutic agents, biologics, and personalized medicine.
Q5: How does the patent landscape impact drug development in China?
A: A rich patent environment encourages innovation, motivates R&D investments, and shapes competitive dynamics, impacting timelines and market entry strategies.
References
- Official CNIPA patent database for CN107624067.
- Recent analyses of China's patent landscape in pharmaceuticals.
- Global patent filing trends in the biotech sector.
